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Metacognitive functioning predicts positive and negative symptoms 
over 12 months in first episode psychosis 
Hamish J. McLeod, Andrew I. Gumley, Angus MacBeth, Matthias Schwannauer, 
Paul H. Lysaker. 
Abstract 
The negative symptoms of schizophrenia are a major source of impairment and distress but both 
pharmacological and psychological treatment options provide only modest benefit. Developing more 
effective psychological treatments for negative symptoms will require a more sophisticated 
understanding of the psychological processes that are implicated in their development and 
maintenance. We extended previous work by demonstrating that metacognitive functioning is related 
to negative symptom expression across the first 12 months of first episode psychosis (FEP). Previous 
studies in this area have either been cross-sectional or have used much older participants with long-
standing symptoms. In this study, forty-five FEP participants were assessed three times over 12 
months and provided data on PANSS rated symptoms, premorbid adjustment, metacognitive 
functioning, and DUP. Step-wise linear regression showed that adding metacognition scores to known 
predictors of negative symptoms (baseline symptom severity, gender, DUP, and premorbid academic 
and social adjustment) accounted for 62% of the variance in PANSS negative symptom scores at six 
months and 38% at 12 months. The same predictors also explained 47% of the variance in positive 
symptoms at both six and 12 months. However, exploration of the simple correlations between 
PANSS symptom scores and metacognition suggests a stronger univariate relationship between 
metacognition and negative symptoms. Overall, the results indicate that problems with mental state 
processing may be important determinants of negative symptom expression from the very early stages 
of psychosis. These results provide further evidence that metacognitive functioning is a potentially 
relevant target for psychological interventions. 
1. Introduction 
The negative symptoms of schizophrenia are associated with lower quality of life (Ho et al., 
1998), reduced psychosocial functioning (Hunter and Barry, 2012), objective carer burden 
(Provencher and Mueser, 1997) and poorer recovery (Milev et al., 2005). These symptoms are evident 
from very early phases of presentation, including in people who are at high risk of developing 
psychosis (Piskulic et al., 2012) and in those experiencing their first episode (Lyne et al., 2012). 
Around one fifth of patients with an established diagnosis of schizophrenia will display enduring 
negative symptoms and improvement with pharmacotherapy is typically incomplete (Murphy et al., 
2006; Buchanan, 2007; Barnes and Paton, 2011; Kendall, 2012). This attenuated pharmacological 
response has contributed to the search for effective adjunctive psychosocial interventions. Although 
recent trial data provide mixed results, there is preliminary evidence that body-oriented psychological 
therapy (Röhricht and Priebe, 2006), cognitivebehavioural therapy (CBT; Klingberg et al., 2011; 
Grant et al., 2012; Staring, 2013), cognitive remediation therapy (CRT; Klingberg et al., 2011), social 
skills training (Elis et al., 2013), and loving kindness meditation training (LKM; Johnson et al., 2011) 
may all promote some improvements in negative symptoms and general functioning. However, the 
most appropriate therapeutic target for psychological interventions remains open to debate, 
highlighting a need for further refinement of the psychological models that can be used to guide 
effective and efficient treatment.  
Current psychological models underpinning CBT-based interventions for negative symptoms 
emphasise the identification and modification of self-defeating cognitions (e.g. “If you cannot do 
something well, there is little point in doing it at all”; Rector et al., 2005; Grant and Beck, 2009). 
These discrete thought patterns have been presented as a key factor in determining whether patients 
overcome other barriers to functioning such as neurocognitive impairment (Grant and Beck, 2009, 
2010) However, there is evidence that more complex metacognitive processes, such as the capacity to 
reflect on and understand one’s own and others’ mental states, are also implicated in the emergence 
and persistence of negative symptoms (Brune, 2005; Nicolo et al., 2012). Though the term 
metacognition originally referred to the ability think about and monitor mental processes during 
learning tasks (Flavell, 1979), contemporary definitions have been broadened to include processes 
involved in generating complex representations of the mental states of the self and others (Semerari et 
al., 2003; Lysaker et al., 2013b). As such, metacognition can be viewed as a spectrum of mental 
activities ranging from discrete acts, such as noticing cognitive errors and biases, identifying specific 
memories, and reporting beliefs (Koren et al., 2006; Moritz et al., 2010), through to more synthetic 
actions that entail integrating and combining multiple sources of information into complex ideas about 
the self and others as unique agents in the world (Dimaggio et al., 2009). Complex synthetic 
metacognitive acts may be particularly important in facilitating interpersonal social functioning and in 
spontaneously deriving meaning from personally experienced events. Current experimental evidence 
suggests that people with schizophrenia marked by prominent negative symptoms are less able than 
healthy controls to spontaneously derive meaning from significant events from their past (Berna et al., 
2011). Getting a clearer characterisation and understanding of these kinds of processes is highly 
relevant to explaining the disturbances of sense of self commonly seen in people with schizophrenia 
(Bennouna-Greene et al., 2012; Mishara et al., 2013).  
A small number of studies have examined the link between negative symptoms and 
metacognitive functioning. These have mostly involved samples of older participants with long 
standing symptoms (Lysaker et al., 2005; Hamm et al., 2012; Nicolo et al., 2012) although one recent 
cross sectional study has included patients in their first episode (MacBeth et al., 2014). The 
examination of negative symptoms across studies has typically involved either the analysis of specific 
PANSS negative scale itemscores or the total negative symptom subscale score. Metacognition has 
typically been measured with variants of the Metacognition Assessment Scale (MAS; Semerari et al., 
2003; Lysaker et al., 2005). This scale indexes metacognition in four domains: the ability to 
understand ones own mind (self-reflectivity), the ability to understand the mind of others, the ability 
to adopt a non-egocentric view of the mind of others (decentration), and the ability to use 
metacognitive information to solve interpersonal problems (mastery).  
In the earliest study (Lysaker et al., 2005), the capacities to understand one’s own mind and 
the mind of others, plus the ability to use this information to solve interpersonal problems were 
correlated with the emotional withdra wal item on the PANSS (r’s¼ .31 to .43). In a recent 
replication, these three aspects of metacognition were also found to be associated with blunted affect 
and disturbances of volition (r’s ¼ .30 to .39; Nicolo et al., 2012). Although Nicolo et al. only 
detected correlations between metacognition and negative symptom scores, Lysaker et al. observed 
correlations between hallucinations and the understanding of one’s own mind (r ¼ .26) and 
suspici ousness and mastery (r ¼ .36). This points to a possible dynamic interaction between 
metacognition and symptoms over time, possibly in response to interpersonal stressors and other 
factors that contribute to symptom provocation and exacerbation. Longitudinal studies are needed to 
clarify these interactions.  
Only one study to date has longitudinally examined the dynamic interaction between negative 
symptoms and metacognition assessed with the MAS. Hamm et al. (2012) assessed a sample of 
people with a long established schizophrenia spectrum disorder (n ¼ 49) at two time points across six 
months. The total score on the MAS-A was used to index metacognition and negative symptoms were 
assessed with the total PANSS negative subscale score. Stepwise linear regression indicated that 
metacognition along with executive functioning (WCST score) were unique predictors of variance in 
negative symptoms at six-month follow-up. This relationship persisted after controlling for initial 
levels of negative symptoms. Because these data were obtained from people who have experienced 
many years of illness it is possible that the effects are a secondary consequence of chronicity. 
However, preliminary evidence suggests that this is not the case. MacBeth et al. (2014) have reported 
an association between PANSS negative symptoms and understanding others minds (r ¼ .44) in a 
cross-sectional study of an FEP sample (n ¼ 34). But the impact of metacognition on the unfolding of 
negative symptoms over the early course of psychosis is not yet determined. Longitudinal exploration 
of the impact of metacognition on negative symptoms over time in a FEP sample will address this gap 
in the current data.  
Any examination of the role of metacognitive factors in the longitudinal prediction of 
negative symptoms should also consider the number of other variables that have already been linked 
to negative symptom development. One of the most robust predictors of negative symptoms in early 
psychosis is premorbid functioning in academic/occupational and social domains (Cannon-Spoor et 
al., 1982). Poorer premorbid adjustment predicts negative symptoms in people at high risk of 
psychosis (Corcoran et al., 2010) and in those in their first episode (Macbeth and Gumley, 2007; 
Chang et al., 2013), independent of DUP. Also, a positive family history of psychosis is associated 
with a more severe negative symptom profile, specifically for male patients with a longer duration of 
untreated psychosis (DUP; Esterberg et al., 2010; Esterberg and Compton, 2012). Furthermore, meta-
analytic evidence indicates that DUP longer than nine months is associated with more persistent and 
severe negative symptoms (Boonstra et al., 2012).  
We sought to determine whether metacognitive capacity was associated with severity of 
negative symptoms assessed at three time points over the first 12 months of early psychosis and 
whether that association persisted after controlling for established predictors of negative symptoms. 
Specifically, we hypothesized that metacognitive functioning measured at six months into the first 
episode of psychosis would predict additional variance in negative symptoms at six and 12 months 
beyond that explained by baseline symptom severity, gender, DUP, and premorbid adjustment. This 
work also included an exploratory component arising from the fact that previous studies have reported 
different patterns of relationship between metacognition and symptom subtypes. To clarify these 
relationships, we also conducted exploratory correlational analyses focused on the MAS-A and 
PANSS subscales. 
2. Methods 
2.1.  Subjects 
The participants were a subgroup taken from a 12-month prospective study conducted in first 
episode psychosis (FEP) services in Edinburgh and Glasgow, Scotland, UK. Ethical (REC: 
04/S0703/91) and managerial approval for the project were obtained before commencement and the 
study was conducted in accordance with the Declaration of Helsinki. Included participants were: (a) 
inpatients or outpatients with (b) first presentation to mental health services for psychosis who (c) met 
DSM-IV-TR criteria for schizophrenia, schizophreniform disorder, schizoaffective disorder, 
delusional disorder, bipolar disorder (American Psychiatric Association, 2000). Individuals were not 
eligible for consent if substance misuse, head injury, or organic disorder were judged to be the 
primary cause of psychotic symptoms.  
One hundred and two eligible participants were approached, 21 declined consent at the outset and 
two withdrew before any baseline data was collected. The full cohort at baseline comprised 79 
participants and 45 of these (57%) provided complete data on the critical study measures over 12 
months. This subgroup did not differ from the main cohort on the key demographic and clinical 
variables. The 45 participants were mostly male (31 versus 14 female) and average age at recruitment 
was 25.7 years (SD ¼ 7.01 years). The majority (71%) had only a high school education, 15.6% 
completed college, and 9% completed a university degree. Thirty one percent were in full time 
employment at recruitment and very few people were receiving inpatient care across the study period 
(3 at baseline, 1 at six months, and 1 at 12 months). The ethnic profile of the samplewas consistent 
with the recruitment settings with the majority describing themselves as White British or White 
Scottish (93%). The diagnostic pattern was as follows: schizophrenia (48%), bipolar affective disorder 
(27%), schizoaffective disorder (16%), delusional disorder (2%), and “other” (7%). 
2.2. Assessments 
2.2.1. Clinical Variables & Psychopathology 
Diagnoses meeting DSM-IV-TR criteria (American Psychiatric Association, 2000) were 
based on semi-structured interviews completed by Research Assistants and diagnostic decisions were 
reviewed and confirmed by qualified clinicians (AG and MS) at monthly research meetings. 
Psychiatric symptoms were assessed using the Positive and Negative Syndrome Scale (PANSS; Kay 
et al., 1987) from which five-factor subscale scores were calculated for positive, negative, 
disorganized, excitement and emotional distress symptoms (van der Gaag et al., 2006). PANSS 
assessments were conducted following entry to the service, at six-months, and 12- month follow-up. 
Inter-rater reliability checks for PANSS ratings were undertaken at 6-monthly intervals for which all 
rho’s were above .80. DUP, was estimated using established methods (Beiser et al., 1993; Skeate et 
al., 2002). Information about the development of psychotic symptomatology was collected from the 
individual and (where possible) a carer or loved one. The test-retest reliability of these DUP 
calculations was good (intraclass coefficient r ¼ .96, p < .01). 
2.2.2. Premorbid Adjustment 
Premorbid adjustment was assessed with the Premorbid Assessment of Functioning (PAS; 
Cannon-Spoor et al., 1982). This measure collates ratings of functioning in particular domains (e.g. 
social withdrawal/sociability, scholastic performance, peer relationships, intimate relationships) 
across the developmental periods of childhood (0e11 years), early adolescence (12e15 years), late 
adolescence (16e18 years), and adulthood (>19 years). The rating scale for each domain ranges from 0 
(normal adjustment) to 6 (severe impairment).We calculated average adjustment scores in the social 
and academic domains across all of the developmental phases completed prior to the onset of 
psychosis. Ratings were based on information provided by participants and key informants such as 
family members. 
2.2.3. Metacognitive Functioning 
Metacognitive ability was coded using the Metacognitive Assessment Scale e Abbreviated 
(MAS-A; Lysaker et al., 2005). This coding system was adapted from the original MAS (Semerari et 
al., 2003) for use with people with schizophrenia. The MAS-A gives four subscale scores. First, the 
Self-reflectivity score indexes the subject’s ability to recognize and differentiate one’s own mental 
functions and integrate these into a coherent narrative. Secondly, Understanding the other’s mind 
conveys the ability to think about the mental states of others and distinguish these from one’s own 
thoughts and feelings. The Decentration subscale captures the ability to take a non-egocentric view of 
the mind of others and recognize that others’ mental states are influenced by a multitude of 
experiential, developmental, and contextual factors. The final subscale, Mastery, reflects the ability to 
use metacognitive awareness to identify, confront, and solve real world problems in context. For each 
scale, higher ratings reflect greater metacognitive capacity.  
This multidimensional formulation of metacognition provides a structured approach to 
assessing the complex processes that underpin emotional, behavioural, and cognitive functioning in 
people with schizophrenia. The source material for these ratings is a naturalistic speech sample 
elicited through a semi-structured interview. We used transcripts obtained from the Adult Attachment 
Interview (AAI; Main et al., 2002), a semi-structured interview with 20 questions and follow-up 
probes. This provided narratives about interpersonal relationships with attachment figures. The 
interviews were transcribed verbatimand then coded with the MAS-A by an independent researcher 
blinded to all other subject details. The AAI was completed at the six-month point of the study. 
2.3. Design & Data Analysis 
This was a within subjects longitudinal study with data obtained at baseline, six months, and 
12 months. The main planned analyses were based on the previous findings of Lysaker et al. (2005) 
and Nicolo et al. (2012). In the first phase, correlations between specific dimensions of metacognition 
and six and 12-month PANSS subscale scores were determined. We then conducted linear regression 
analyses to determine whether metacognitive abilities predicted additional variance in negative 
symptom scores beyond that explained by established predictors such as DUP, gender, premorbid 
functioning, and initial symptom severity. In order to explore the specificity of the relationship of 
metacognition to negative symptoms, we conducted the same regression analyses using the PANSS 
positive symptom score as the dependent variable. These models were tested for the positive and 
negative symptom subscale scores at six and 12 months. Only participants with complete data for all 
variables were retained in these analyses. Also, because of skewness, DUP was transformed to its 
natural logarithm. Because the analyses were derived from results reported in previous studies we did 
not adjust alpha to control for multiple correlations. We used SPSS Version 19 to conduct all analyses 
(see Table 1 for descriptive data on premorbid functioning, metacognition, and symptoms). 
3. Results 
The first set of analyses adopted the approach of previous studies (Lysaker et al., 2005; Nicolo et 
al., 2012) and correlated the four subscales assessed by the MAS-A with PANSS symptom subscale 
scores at six and 12 months (see Table 2). No simple correlations were observed between 
metacognition and positive symptoms at either time point. In contrast, negative symptoms at six 
months were significantly correlated with decentration and mastery and trends were evident for 
understanding other minds (r ¼  .292, p ¼ .054) and self- reflectivity (r ¼ .272, p ¼ .074). All 
correlations were in the expected direction. No significant effects were observed at 12 months but the 
association between negative symptoms and decentration approached significance (r ¼ .275, p ¼ 
.071) as did the relationship between d ecentration and disorganisation (r ¼ .293, p ¼ .054).  
The other predictors of negative symptoms showed a mixed pattern of correlations. Six and 12-
month negative symptom ratings were correlated with PAS premorbid social functioning (r ¼.340, p 
¼ .022 and r ¼.329, p ¼ .027). Negative symptoms at 12 months were correlated with PAS premorbid 
academic functioning (r ¼ .299, p ¼ .046) but this relationship was not significant at six months (r ¼ 
.245, p ¼ .105). DUP was not correlated with negative symptoms at either time. Overall, these results 
indicate a mixed pattern of relationships between negative symptoms and various predictors and 
correlates. We examined the combined effects of these relationships in more detail with regression 
analyses.  
Step-wise linear regression was used to examine the association between negative symptom 
scores, other predictors (gender, DUP and premorbid adjustment), and metacognition. As expected, 
adding the MAS-A scores to the model predicting negative symptoms at six months increased the 
proportion of explained variance to nearly 62%, up from 49% to 55% at the first and second steps (see 
Table 3). This combination of predictors also explained 38% of the variance of negative symptoms at 
12 months. The models for positive symptoms at six and 12 months were also significant with the 
same predictors accounting for approximately 47% of the variance in PANSS positive symptom 
scores at both time points. In order to better understand the impact of specific predictors on the 
PANSS negative symptom subscale scores at six and 12 months, the beta coefficients for each model 
were scrutinised. At the six-month assessment, none of the beta weights for the MAS-A subscales 
were significant individual predictors of the overall variance in the PANSS negative symptom 
subscale score. In contrast, for the model predicting negative symptoms at 12 months, Understanding 
the Others Mind made a significant contribution to the model (b ¼ .658, t ¼ 2.567, p ¼ .015) but none 
of the other variables stood out as significant unique predictors. 
4. Discussion 
We sought to replicate and extend previous research that has shown an association between 
metacognition and negative symptoms (Lysaker et al., 2005; Hamm et al., 2012; Nicolo et al., 2012). 
We found that 62% of the variance in the severity of negative symptoms assessed at the sixth month 
of a first episode of psychosis was explained by a model comprising metacognition, DUP, gender, and 
premorbid adjustment. Although positive symptoms were not a primary focus of this study, it is 
appropriate to highlight that this pattern was also evident for the prediction of positive symptoms, 
with 47% of the variance at six months explained by the full model. The same pattern was seen for the 
12- month data with variance in both positive and negative symptoms being predicted by 
metacognition scores. To the best of our knowledge this is the first study to provide longitudinal 
evidence that metacognitive factors are implicated in the expression of positive and negative 
symptoms in the early stages of psychosis.  
Interestingly, decentration emerged as the aspect of metacognition most strongly correlated with 
negative symptoms. The association between decentration and negative symptoms has not been 
investigated in previous studies so this effect represents a new finding that may be worthy of further 
investigation. The MAS-A decentration subscale indexes the ability to take a non-egocentric 
perspective on the thoughts, desires, and motives of others and, at more complex levels, reflects the 
ability to think about others’ actions as arising from their own unique developmental history and 
experiences. One interpretation of this result is that negative symptoms are associated with increased 
self-focused attention with the accompanying distorted view that others are also focused on the 
patient. Difficulty perceiving events as unrelated to oneself may prompt the use of withdrawal and 
concealment strategies such as reducing affective expression, disengaging from others, and down-
regulating goal pursuit (i.e. affective blunting, emotional withdrawal, and avolition). This 
interpretation is consistent with evidence that negative symptoms are associated with high levels of 
ruminative self-focus (Halari et al., 2009). It also fits with the proposition that negative symptoms 
arise from broader problems with simulating the mental states of others in a dynamic and “online” 
fashion (Salvatore et al., 2007). A diminished ability to rapidly select viable hypotheses about the 
mental states of others commonly provokes the use of withdrawal and avoidance strategies. This view 
is also consistent with the correlation between negative symptoms and the mastery scale, which 
indicates that worse negative symptoms were associated with greater difficulty using mental state 
information to solve interpersonal problems and challenges.  
The regression analyses indicate that metacognitive functioning relates to the expression of 
symptoms both concurrently and prospectively. At six months, MAS-A scores explained additional 
variance compared to DUP, gender, and premorbid functioning. The same model for negative 
symptoms at 12 months only achieved significance when metacognition scores were included. These 
data suggest a persistent effect of metacognition on negative symptom maintenance and recovery. 
One preliminary conclusion that could be drawn from the pattern of beta coefficients for the models 
predicting negative symptoms at six and 12 months is that difficulties with representing and 
understanding the mind of others may be particularly relevant to the persistence of negative 
symptoms.  
The regression analyses also indicate a link between metacognition and positive symptoms but the 
univariate correlations suggest that this effect may be less direct. When tested in the regression 
models, it was apparent that MAS-A scores predicted additional variance in the six-month and 12-
month PANSS positive symptom scores despite the absence of simple correlations. The general 
finding that metacognitive processes are associated with positive symptoms is consistent with 
previous research but a lot of these previous studies have focused on discrete aspects of metacognition 
such as specific theory of mind tasks (Pickup and Frith, 2001; Brune, 2005; Bora et al., 2009). One 
possibility is that negative symptoms are more strongly related to disturbances of complex synthetic 
metacognitive functioning whereas positive symptoms arise from more specific discrete problems 
with making inferences about the mental states of others. Further refinement of multifactorial models 
of positive and negative symptoms should clarify these issues. 
Future studies should also address the limitations of the current work. Although the sample size 
obtained here is larger than that achieved in previous cross-sectional work with FEP participants 
(MacBeth et al., 2014) and greater than other longitudinal studies using the MAS-A (Hamm et al., 
2012), it would be desirable to replicate this result with a larger sample. Also, replication of the 
effects in a sample drawn from a generic mental health service context will help demonstrate 
generalizability of the findings beyond specialist FEP service contexts. Other improvements in future 
studies would include the assessment of metacognition longitudinally in order to better characterise 
the hypothesised dynamic interaction between symptom levels and metacognitive functioning. 
Acquiring a better understanding of any such interactions will be important for determining which 
aspects of metacognition are associated with specific fluctuations in symptom expression over time. 
A final point that is left unaddressed by the current study is the degree to which the metacognitive 
abilities measured on the MASA are linked to deficits in broader domains of neurocognitive 
functioning. For example, problems with memory and executive functioning are well-established 
correlates of a diagnosis of schizophrenia (Heinrichs and Zakzanis, 1998; Aleman et al., 1999) and so 
there has been some debate whether metacognitive problems such as impaired Theory of Mind can be 
attributed to deficits in more discrete cognitive domains (see Brune, 2005 for review). Data from 
previous studies suggest that although metacognitive ability is associated with poorer performance in 
domains such as executive functioning, general intelligence, memory, and social cognition, these 
relationships do not explain the associations seen between dimensional measures of metacognition 
(such as the MAS-A) and specific symptoms (Lysaker et al., 2007, 2008, 2013a). Furthermore, studies 
with non-psychiatric comparison subjects who are suffering adversity (e.g. HIV-AIDS patients) 
indicate that the deficits in metacognition are not simply explained by levels of life stress (Lysaker et 
al., 2012). Other studies using alternative assessment methods such as the Metacognitions 
Questionnaire (Cartwright-Hatton and Wells, 1997) show clear differences between patients and 
controls, leading to the suggestion that disturbances of metacognitive ability may be a general 
vulnerability factor for mental health problems (Morrison and Wells, 2003). The findings of the 
current study provide some support for this view Metacognitive difficulties early in the ontogeny of 
psychosis may interact with other risk factors such as gender and premorbid adjustment to elevate the 
risk of arrested or attenuated symptom recovery. Future studies could extend this work by examining 
how much specific types of neurocognitive impairment add to the prediction of symptom expression 
and recovery beyond the variance explained in the models presented in the current work.  
Overall, our results provide new evidence that greater difficulty with forming and integrating 
ideas about ones own mind and the mind of others affects negative symptom expression across the 
early phase of psychosis. This points to the potential benefit of applying metacognitively oriented 
psychotherapy for schizophrenia (e.g. Lysaker et al., 2010) to foster recovery. This approach may be 
particularly suitable for patients who have more severe metacognitive processing difficulties that 
undermine the performance of discrete metacognitive tasks such as accurately differentiating specific 
thoughts and emotions. These kinds of more severe metacognitive difficulties may restrict the scope 
for engaging in standard CBT strategies that rely on promoting the detection and challenging of 
specific dysfunctional cognitions (e.g. defeatist beliefs; Rector et al., 2005). Also, the observed 
association between negative symptoms and decentration and mastery scores may also point to the 
need to explicitly help FEP patients to develop the capacity to understand others in a de-centred way. 
Examining these issues longitudinally in the context of a case series or treatment trial will provide the 
opportunity to test whether changes in metacognition occur prior to symptom change. Such temporal 
decomposition of the proposed mediators of therapeutic effect will be needed in order to demonstrate 
that metacognitive processes are relevant and viable targets for psychological interventions for 
psychosis (Kazdin, 2007). 
 
